FMIBlog

Global Non-Silicone Emulsion Defoamer Market Set for Strong Growth as Manufacturers Embrace Innovation and Expansion

The global non-silicone emulsion defoamer market is experiencing a significant upswing, with the industry valued at ...

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.
AZoNano

Enhancing Lipid Nanoparticle Stability for Faster Pharmaceutical Development

Turbiscan technology accelerates lipid nanoparticle stability testing and supports robust pharmaceutical formulation ...
Frontiers

The physiological and pharmaceutical roles of MCTs and other ingredients in intravenous emulsions containing omega-3 enriched fish oil designed to mitigate cytokine release ...

Cytokine release syndrome (CRS) is a serious adverse effect often seen following the administration of cancer immunotherapy, particularly with chimeric antigen receptor (CAR) T cell therapy. Recently, ...
C&EN

Skin and Wound Healing: Conventional Dosage versus Nanobased Emulsions Forms

PostGraduate Program in Molecular and Cellular Biology, Department of Physiological Sciences − Pharmacology, Biomedical Institute, Federal University of the State of Rio de Janeiro, Rio de Janeiro ...
KOIN 6

Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...